Quality Management BPI - New Contract

The current contract is set to expire in September 2026, and QMOE plans to seek approval for a new five-year contract beginning at that time, structured as one base year with four additional option years. The anticipated total value of the new contract is approximately $15 million, with an average annual value of $3 million over the full term. QMOE intends to fund part of this contract using its annual $1.5 million allocation from MDUFA V operational funds. The proposed contract falls under the NAICS code 561990 and is being pursued by the Food and Drug Administration for Quality Management services under the title Quality Management BPI - New Contract. While the solicitation number is not yet assigned, the forecast is scheduled to be posted on May 25, 2026, with the point of contact for program inquiries being the CDRH Acquisition Liaison at cdrhacquisitions@fda.hhs.gov and the contracting officer position to be determined.